{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:16:34Z","timestamp":1775744194224,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1016\/j.ijantimicag.2003.08.004","type":"journal-article","created":{"date-parts":[[2003,9,16]],"date-time":"2003-09-16T22:58:25Z","timestamp":1063753105000},"page":"15-24","source":"Crossref","is-referenced-by-count":39,"special_numbering":"S1","title":["The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones"],"prefix":"10.1016","volume":"22","author":[{"given":"Roman","family":"Pallares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuncion","family":"Fenoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Li\u00f1ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00431-001-0907-3","article-title":"Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management","volume":"161","author":"Cartwright","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/00365540110026818","article-title":"Invasive pneumococcal disease in Southwestern Sweden: a second follow-up period of 15 years","volume":"33","author":"Dahl","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijantimicag.2003.08.004_BIB3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.275.3.194","article-title":"Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group","volume":"275","author":"Plouffe","year":"1996","journal-title":"J. Am. Med. Assoc."},{"issue":"11","key":"10.1016\/j.ijantimicag.2003.08.004_BIB4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1651-2227.2002.tb00137.x","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in children in an area of Barcelona, Spain","volume":"91","author":"Pineda","year":"2002","journal-title":"Acta Paediatr. (Oslo, Norway: 1992)"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archinte.160.1.89","article-title":"Invasive pneumococcal infection in Baltimore, MD: implications for immunization policy","volume":"160","author":"Harrison","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumooccal disease. Active Bacterial Core Surveillance Team","volume":"342","author":"Nuorti","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB7","first-page":"505","article-title":"Invasive pneumococcal disease in Australia 2001","volume":"26","author":"Roche","year":"2001","journal-title":"Commun. Dis. Intell."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/clinids\/22.3.437","article-title":"Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus","volume":"22","author":"Meynard","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1001\/archinte.155.15.1649","article-title":"High alcohol intake as a risk and prognostic factor for community-acquired pneumonia","volume":"155","author":"Fernandez Sola","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/infdis\/132.1.55","article-title":"Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types","volume":"132","author":"Hendley","year":"1975","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB11","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1542\/peds.103.3.e28","article-title":"Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America","volume":"103","author":"Levine","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.273.11.859","article-title":"Risk factors for primary invasive pneumococcal disease among children in Finland","volume":"273","author":"Takala","year":"1995","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMra021771","article-title":"How contagious are common respiratory tract infections","volume":"348","author":"Musher","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1473-3099(02)00316-X","article-title":"Treatment of drug-resistant pneumococcal pneumonia","volume":"2","author":"Garau","year":"2002","journal-title":"Lancet, Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/CMR.3.2.171","article-title":"Pneumococcal resistance to antibiotics","volume":"3","author":"Klugman","year":"1990","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.43.2.357","article-title":"Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996\u20131997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens","volume":"43","author":"Baquero","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB18","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB19","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB20","doi-asserted-by":"crossref","unstructured":"Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997\u20131999. Clin Infect Dis 2001;(Suppl. 2):S81\u201393.","DOI":"10.1086\/320181"},{"issue":"Suppl. T1","key":"10.1016\/j.ijantimicag.2003.08.004_BIB21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jac.a020891","article-title":"The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project","volume":"46","author":"Schito","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB22","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement, M100-S12. Wayne, PA, USA, 2002."},{"issue":"Suppl. S2","key":"10.1016\/j.ijantimicag.2003.08.004_BIB24","first-page":"13","article-title":"Antimicrobial susceptibility and pneumococcal serotypes","volume":"50","author":"Fenoll","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/13.1.56","article-title":"Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979\u20131989","volume":"13","author":"Fenoll","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB26","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/JCM.36.12.3447-3454.1998","article-title":"Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990\u20131996)","volume":"36","author":"Fenoll","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.ijantimicag.2003.08.004_BIB27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jac\/45.3.395","article-title":"Non-hospital consumption of antibiotics in Spain: 1987\u20131997","volume":"45","author":"Bremon","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/mdr.1996.2.183","article-title":"Penicillin-binding proteins 2x and 2b as primary PBP targets in Streptococcus pneumoniae","volume":"2","author":"Krauss","year":"1996","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/jac\/30.3.279","article-title":"Decreased susceptibility of penicillin-resistant pneumococci to twenty four \u03b2-lactam antibiotics","volume":"30","author":"Li\u0148ares","year":"1992","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB30","first-page":"403","article-title":"Resistance to macrolides mediated by efflux mechanism","volume":"1","author":"Sutcliffe","year":"1999","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/AAC.35.7.1267","article-title":"Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification","volume":"35","author":"Leclercq","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1128\/JCM.39.4.1311-1315.2001","article-title":"Differentiation of resistance phenotypes among erythromycin-resistant pneumococci","volume":"39","author":"Montanari","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB33","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1128\/AAC.42.9.2425","article-title":"Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae","volume":"42","author":"Johnston","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB34","unstructured":"Li\u0148ares J, Tubau F, Dominguez MA, Martin R, Spanish Collaborative Group. Macrolide-resistant Streptococcus pneumoniae (MRSp): a Spanish multicenter study of in vitro activities of grepafloxacin and 12 antimicrobials against 300 MRSp strains: characterization of MRSp phenotypes, Proceedings of the 39th interscience conference on antimicrobial agents and chemotherapy. San Francisco, USA, 1999. Abstract 75."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/47.6.863","article-title":"Distribution of resistance genes tet(M), aph3\u2032-III, catpC194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain","volume":"47","author":"Seral","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB36","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/AAC.43.10.2510","article-title":"Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates","volume":"43","author":"Oster","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/44.4.461","article-title":"Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy","volume":"44","author":"Marchese","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB38","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/AAC.45.2.636-638.2001","article-title":"Mechanisms of macrolide resistance in clinical pneumococcal isolates in France","volume":"45","author":"Fitoussi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/45.1.119","article-title":"Macrolide resistance in Belgian Streptococcus pneumoniae","volume":"45","author":"Lagrou","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/318118","article-title":"Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life","volume":"31","author":"Syrogiannopoulos","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/jac\/42.6.729","article-title":"Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates","volume":"42","author":"Klugman","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/jac\/43.5.637","article-title":"Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics","volume":"43","author":"Nishijima","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jac\/dkf146","article-title":"Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin","volume":"50","author":"Weiss","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB44","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/315853","article-title":"The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment","volume":"182","author":"Gay","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB45","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/313452","article-title":"Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994\u20131995","volume":"29","author":"Shortridge","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0924-8579(02)00122-X","article-title":"Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile","volume":"20","author":"Palavecino","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB47","series-title":"Streptococcus pneumonia molecular biology and mechanisms of disease","first-page":"399","article-title":"Antibiotic resistance in Streptococcus pneumoniae in Spain: an overview of the 1990s","author":"Li\u0148ares","year":"2000"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB48","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/AAC.45.12.3334-3340.2001","article-title":"Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998\u20131999) multicenter surveillance study in Spain","volume":"45","author":"P\u00e9rez Trallero","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB50","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/AAC.40.12.2760","article-title":"High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA","volume":"40","author":"Janoir","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB51","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.40.10.2252","article-title":"ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype","volume":"40","author":"Munoz","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB53","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJM199911113412013","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"341","author":"Li\u0148ares","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB54","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB55","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s100960050202","article-title":"Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children","volume":"17","author":"Melander","year":"1998","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB56","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/clinids\/19.5.884","article-title":"Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study","volume":"19","author":"Nava","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB57","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3476(96)70326-8","article-title":"Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee","volume":"128","author":"Arnold","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB58","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/157.2.256","article-title":"Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care","volume":"157","author":"Henderson","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM198707023170104","article-title":"Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci","volume":"317","author":"Pallares","year":"1987","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijantimicag.2003.08.004_BIB60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/clinids\/22.1.63","article-title":"Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey","volume":"22","author":"Bedos","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB61","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/clinids\/20.5.1195","article-title":"Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study","volume":"20","author":"Moreno","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB62","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1086\/319222","article-title":"Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study","volume":"32","author":"Ho","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB63","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.45.10.2765-2770.2001","article-title":"Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong","volume":"45","author":"Chiu","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/000992289703600401","article-title":"Risk factors for penicillin-resistant systemic pneumococcal infections in children","volume":"36","author":"Doone","year":"1997","journal-title":"Clin. Pediatr."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB65","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/clinids\/22.6.966","article-title":"Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates","volume":"22","author":"Fairchok","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.279.5.365","article-title":"Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae","volume":"279","author":"Guillemot","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.286.1.49","article-title":"Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial","volume":"286","author":"Schrag","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB68","unstructured":"Centers for Disease Control. Resistance of Streptococcus pneumoniae to fluoroquinolones-United States, 1995\u20131999. Morbid Mortal Weekly Rep. 2001;50:800\u20134."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB69","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/344768","article-title":"Widespread use of fluoroquinolones versus emerging resistance in pneumococci","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB70","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/AAC.39.10.2171","article-title":"Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae","volume":"39","author":"Paris","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB71","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/AAC.40.1.218","article-title":"High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins","volume":"40","author":"Viladrich","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB72","first-page":"276","article-title":"Treatment of pneumococcal pneumonia","volume":"14","author":"Pallares","year":"1999","journal-title":"Semin. Respir. Infect."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB73","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/516340","article-title":"Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children","volume":"26","author":"Choi","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1542\/peds.103.2.409","article-title":"Risk factors and course of illness among children with invsive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group","volume":"103","author":"Deeks","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB76","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB77","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance","volume":"33","author":"Moroney","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00006454-200104000-00005","article-title":"Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with \u03b2-lactam antibiotics","volume":"20","author":"Kaplan","year":"2001","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/107662901750152864","article-title":"Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin\u2013clavulanate and ceftriaxone","volume":"7","author":"Roson","year":"2001","journal-title":"Microbial. Drug Resist."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0924-8579(02)00127-9","article-title":"Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strains","volume":"20","author":"Quach","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB81","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0002-9343(02)01162-2","article-title":"The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections","volume":"113","author":"Pallares","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB83","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1128\/AAC.42.9.2375","article-title":"In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations","volume":"42","author":"Andes","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB84","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/313976","article-title":"Bacteremic pneumonia due to multidrug-resistant pneumococci in three patients treated unsuccessfully with azithromycin and successfully with levofloxacin","volume":"31","author":"Fogarty","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB85","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB86","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1378\/chest.118.6.1839-a","article-title":"Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy","volume":"118","author":"Waterer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB87","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB88","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB89","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nm839","article-title":"Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States","volume":"9","author":"McCormick","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB90","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199108153250719","article-title":"Infectious complications with respiratory pathogens despite ciprofloxacin therapy","volume":"325","author":"Lee","year":"1991","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB91","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jac\/44.4.425","article-title":"Will pneumococci put quinolones in their place","volume":"44","author":"Legg","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB92","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1086\/313958","article-title":"Levofloxacin-resistant pneumococcus","volume":"31","author":"Klugman","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB93","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-131-4-199908170-00023","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"131","author":"Kuehnert","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB94","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1086\/313557","article-title":"Fatal meningitis due to levofloxacin-resistant Streptococcus pneumoniae","volume":"29","author":"Wortmann","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB95","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/322658","article-title":"A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae","volume":"33","author":"Weiss","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ijantimicag.2003.08.004_BIB96","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB97","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/AAC.47.4.1419-1422.2003","article-title":"Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasis","volume":"47","author":"de la Campa","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB98","unstructured":"Pallares R, Li\u0148ares J, Tubau F, et al. Prevalence of ceftriaxone\/cefotaxime resistance in non-meningeal pneumococcal infections according to new NCCLS breakpoints, Proceedings of the 42nd interscience conference on antimicrobial agents and chemotherapy, San Diego, USA, 2002. Abstract L-994."},{"key":"10.1016\/j.ijantimicag.2003.08.004_BIB99","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1128\/JCM.40.11.4332-4333.2002","article-title":"Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997\u20132001)","volume":"40","author":"Jones","year":"2002","journal-title":"J. Clin. Microbiol."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903002784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857903002784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T16:05:02Z","timestamp":1585152302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857903002784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":98,"alternative-id":["S0924857903002784"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.08.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}